Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, announces the commercial availability of several new products to enhance next-generation sequencing including its Twist Human Core Exome Kit, an innovative and comprehensive library preparation and target enrichment kit, and its custom panels offering, that can be tailored to individual requests.
The new exome and custom target enrichment solutions are designed to provide improved performance, versatility and maximum capture efficiency to reduce the overall cost of next-generation sequencing.
“This product line demonstrates the true platform nature of our technology, bringing the power of DNA writing to amplify and enrich the process of DNA reading,” says Emily M. Leproust, Ph.D., CEO of Twist Bioscience. “By leveraging our DNA synthesis technology to deliver precision at scale, we are excited to introduce a new line of next-generation sequencing tools focused on exome and custom capture. We believe these steps in the sequencing workflow are pivotal to effective genome analysis but have traditionally been less than efficient until now.”
As a component of offering the Human Core Exome Kit, Twist Bioscience will offer customers the option of adding IntegraGen’s cloud-based platforms, Mercury and Sirius, for analysis of germline or cancer samples.
For more details, visit the website: https://twistbioscience.com/